Mark J. Levin's most recent trade in Fulcrum Therapeutics Inc was a trade of 1,000,000 Common Stock done . Disclosure was reported to the exchange on Nov. 10, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics Inc | Mark J. Levin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Nov 2021 | 1,000,000 | 3,962,202 (16%) | 4% | - | Common Stock | |
| Fulcrum Therapeutics Inc | Mark J. Levin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Sep 2021 | 1,000,000 | 4,962,202 (21%) | 4% | - | Common Stock | |
| Fulcrum Therapeutics Inc | Mark J. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Voyager Therapeutics Inc | Mark J. Levin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |